The Impact of Race on the Efficacy of Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions

被引：0
|
作者：
Osathanugrah, Pawarissara [1 ]
Prasad, Minali [1 ]
Sanjiv, Nayan [1 ]
Ness, Steven [1 ]
Siegel, Nicole H. [1 ]
Chen, Xuejing [1 ]
Subramanian, Manju L. [1 ]
机构：
[1] Boston Med Ctr, Ophthalmol, Boston, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1760
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long Term Efficacy of Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions
    He, Xining
    Elia, Maxwell
    Hsieh, Eric
    Adelman, Ron A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [2] The impact of socioeconomic factors on the efficacy of bevacizumab for macular edema secondary to retinal vein occlusion
    Sanjiv, Nayan
    Prasad, Minali
    Goodman, Deniz
    Osathanugrah, Pawarissara
    Chen, Xuejing
    Ness, Steven
    Siegel, Nicole
    Subramanian, Manju L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [3] Real World Comparison Of Ranbiziumab And Bevacizumab For Macular Edema Secondary To Retinal Vein Occlusions
    Khan, Mehnaz
    Wai, Karen M.
    Silva, Fabiana Q.
    Srivastava, Sunil K.
    Ehlers, Justis P.
    Rachitskaya, Aleksandra
    Deasy, Ryan
    Schachat, Andrew
    Kaiser, Peter K.
    Yuan, Alex
    Singh, Rishi P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Bevacizumab in the treatment of macular edema complicating retinal vein occlusions
    Urrets-Zavalia, Julio A.
    Eugenia Gonzalez-Castellanos, M.
    Esposito, Evangelina
    Crim, Nicolas
    Correa, Leandro
    Martinez, Dana
    Fernanda Barros-Centeno, M.
    Serra, Horacio M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] Bevacizumab and Ranibizumab for Macular Edema due to Retinal Vein Occlusions
    Niederhauser, N.
    Valmaggia, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2013, 230 (04) : 405 - 408
  • [6] Management of macular edema secondary to retinal vein occlusions
    Ciardella, Antonio P.
    Morara, Mariachiara
    Pichi, Francesco
    Alkabes, Micol
    Romano, Simona
    Nucci, Paolo
    EXPERT REVIEW OF OPHTHALMOLOGY, 2011, 6 (05) : 557 - 564
  • [7] Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice
    Khan, Mehnaz
    Wai, Karen M.
    Silva, Fabiana Q.
    Srivastava, Sunil
    Ehlers, Justis P.
    Rachitskaya, Aleksandra
    Babiuch, Amy
    Deasy, Ryan
    Kaiser, Peter K.
    Schachat, Andrew P.
    Yuan, Alex
    Singh, Rishi P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (06): : 465 - 472
  • [8] Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusion
    Parajuli, Anil
    Joshi, Purushottam
    Subedi, Prabha
    Pradhan, Chandni
    NEPALESE JOURNAL OF OPHTHALMOLOGY, 2020, 12 (02) : 281 - 289
  • [9] Bevacizumab for treatment of macular edema secondary to retinal vein occlusion
    Jaissle, G. B.
    Ziemssen, F.
    Petermeier, K.
    Szurman, P.
    Ladewig, M.
    Gelisken, F.
    Voelker, M.
    Holz, F. G.
    Bartz-Schmidt, K. U.
    OPHTHALMOLOGE, 2006, 103 (06): : 471 - 475
  • [10] Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Schaal, K. B.
    Hoeh, A. E.
    Scheuerle, A.
    Schuett, F.
    Dithmar, S.
    OPHTHALMOLOGE, 2007, 104 (04): : 285 - 289
12345